1. Targeted Ultrasound-Triggered Phase Transition Nanodroplets for Her2-Overexpressing Breast Cancer Diagnosis and Gene Transfection
- Author
-
Yingqin Li, Xiaoyan Xie, Luyao Zhou, Di Gao, Zhong Cao, Wei Wang, Jie Liu, Jinbiao Gao, Ming Xu, and Qing Jiang
- Subjects
Polymers ,Receptor, ErbB-2 ,Genetic enhancement ,Mice, Nude ,Pharmaceutical Science ,Breast Neoplasms ,Peptide ,02 engineering and technology ,Gene delivery ,Transfection ,010402 general chemistry ,01 natural sciences ,Phase Transition ,Mice ,Breast cancer ,Cell Line, Tumor ,Nucleic Acids ,Drug Discovery ,medicine ,Animals ,Humans ,Gene ,Ultrasonography ,chemistry.chemical_classification ,Fluorocarbons ,Mice, Inbred BALB C ,Chemistry ,021001 nanoscience & nanotechnology ,medicine.disease ,Polyelectrolytes ,Molecular biology ,0104 chemical sciences ,Amino acid ,Nucleic acid ,Cancer research ,Nanoparticles ,Molecular Medicine ,Female ,Peptides ,0210 nano-technology - Abstract
For successful gene therapy, it is imperative to accumulate therapeutic gene in tumor tissues followed by efficiently delivering gene into targeted cells. Ultrasound irradiation, as a noninvasive and cost-effective external stimulus, has been proved to be one of the most potential external-stimulating gene delivery strategies recently in further improving gene transfection. In this study, we developed tumor-targeting ultrasound-triggered phase-transition nanodroplets AHNP-PFP-TNDs comprising a perfluorinated poly(amino acid) C11F17–PAsp (DET) as a core for simultaneously loading perfluoropentane (PFP) and nucleic acids, and a polyanionic polymer PGA-g-PEG-AHNP as the shell for not only modifying the surface of nanodroplets but also introducing an anti-Her2/neu peptide (AHNP) aiming to targeted treatment of Her2-overexpressing breast cancer. The results showed the average diameter of AHNP-PFP-TNDs was below 400 nm, nearly spherical in shape. The modification of PGA-g-PEG-AHNP not only increased the serum s...
- Published
- 2017